FMR LLC

Position in OABIW — OmniAb, Inc.

CIK 315066 BOSTON, MA

Position in OABIW

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

+$0 QoQ

Shares Held

199,818

+5.4% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,175,833 across 370 Biotechnology names. OABIW ranks #367 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	199,818	+5.4%	Shares	Defined	2026-08-13
2026-03-31	—	189,536	-4.7%	Shares	Defined	2026-05-15
2025-12-31	—	198,980	+28.8%	Shares	Defined	2026-02-17
2025-09-30	—	154,546	+12.2%	Shares	Defined	2025-11-13
2025-06-30	—	137,801	+4.8%	Shares	Defined	2025-08-14
2025-03-31	—	131,526	-15.5%	Shares	Defined	2025-05-12
2024-12-31	—	155,610	+12.1%	Shares	Defined	2025-02-13
2024-09-30	—	138,813	+10.6%	Shares	Defined	2024-11-13
2024-06-30	—	125,489	+6.7%	Shares	Defined	2024-08-13
2024-03-31	—	117,653	+2.4%	Shares	Defined	2024-05-13
2023-12-31	—	114,929	+153.5%	Shares	Defined	2024-02-13
2023-09-30	—	45,343	+616.4%	Shares	Defined	2023-11-13
2023-06-30	—	6,329	-2.1%	Shares	Defined	2023-08-11
2023-03-31	—	6,466	+5.8%	Shares	Defined	2023-08-11
2022-12-31	—	6,110	—	Shares	Defined	2023-02-13
No filing history on record for this holder in this stock.